64 results on '"Maurer, Konrad"'
Search Results
2. Long term treatment of SDAT patients with pyritinol
3. Cognitive enhancing properties of antagonist β-carbolines: new insights into clinical research on the treatment of dementias?
4. In vivo studies of hippocampal atrophy in Alzheimer’s disease
5. EEG- and cognitive changes in Alzheimer’s disease — a correlative follow-up study
6. Drug treatment of dementia
7. Single photon emission computed tomography (SPECT) in Pick’s disease: two case reports
8. Outline for the evaluation of nootropic drugs
9. High resolution regional cerebral blood flow measurements in Alzheimer’s disease and other dementia disorders
10. Comparison between cerebral glucose metabolism and late evoked potentials in patients with Alzheimer’s disease
11. PET criteria for diagnosis of Alzheimer’s disease and other dementias
12. Decreased hippocampal metabolic rate in patients with SDAT assessed by positron emission tomography during olfactory memory task
13. Positron emission tomography for differential diagnosis of dementia: a case of familial dementia
14. Oxygen metabolism in the degenerative dementias
15. Sequential clinical approach to differential diagnosis of dementia
16. Regulation of EEG delta activity by the cholinergic nucleus basalis
17. Results of EEG brain mapping and neuroimaging methods in Senile Dementia of Alzheimer’s Typ (SDAT) and Vascular Dementia (VD)
18. Do old patients with Down’s syndrome develop premature brain atrophy?
19. Clinical aspects and terminology of dementing syndromes
20. Characteristics of learning deficit induced by ibotenic acid lesion of the frontal cortex in rats
21. The Alzheimer patient in the family context: how to help the family to cope
22. Towards a clinically specific profile of severe senile primary degenerative dementia of the Alzheimer type (PDDAT)
23. Cognitive deterioration and dementia outcome in depression: the search for prognostic factors
24. Diagnostic significance of language evaluation in early stages of Alzheimer’s disease
25. Alzheimer’s disease — one, two or several?
26. Clinical diagnosis of Alzheimer’s disease: DSM-III-R, ICD-10 — what else?
27. Diagnostic criteria of Alzheimer’s disease
28. Alterations in catecholamine neurons in the locus coeruleus in dementias of Alzheimer’s and Parkinson’s disease
29. Neuroendocrine dysfunction in early-onset Alzheimer’s disease
30. Urinary excretion of salsolinol enantiomers and 1,2-dehydrosalsolinol in patients with degenerative dementia
31. Nerve growth factor in serum of patients with dementia (Alzheimer type)
32. Somatostatin-like immunoreactivity and neurotransmitter metabolites in the cerebrospinal fluid of patients with senile dementia of Alzheimer type and Parkinson’s disease
33. Neurodegenerative diseases: CSF amines, lactate and clinical findings
34. Convulsant properties of methylxanthines, potential cognitive enhancers in dementia syndromes
35. Calbindin immunoreactive neurones in Alzheimer-type dementia
36. The sequence within the two polyadenylation sites of the A4 amyloid peptide precursor stimulates the translation
37. Memory loss by glutamate antagonists: an animal model of Alzheimer’s disease?
38. Alzheimer-like changes of cortical amino acid transmitters in elderly Down’s syndrome
39. Excitatory dicarboxylic amino acid and pyramidal neurone neurotransmission of the cerebral cortex in Alzheimer’s disease
40. Postreceptorial enhancement of neurotransmission for the treatment of cognitive disorders
41. Tyrosine hydroxylase, tryptophan hydroxylase, biopterin and neopterin in the brains and biopterin and neopterin in sera from patients with Alzheimer’s disease
42. Hippocampal and cardiovascular effects of muscarinic agents
43. Cholinergic and monoaminergic neuromediator systems in DAT. Neuropathological and neurochemical findings
44. Choline-acetyltransferase immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer’s disease
45. Acetylcholine synthesis and membrane phospholipids
46. Impairment of cerebral glucose metabolism parallels learning and memory dysfunctions after intracerebral streptozotocin
47. Lactate production and glycolytic enzymes in sporadic and familial Alzheimer’s disease
48. Choline levels, the regulation of acetylcholine and phosphatidylcholine synthesis, and Alzheimer’s disease
49. Quantitative investigations of presenile and senile changes of the human entorhinal region
50. Morphology of the cerebral cortex in relation to Alzheimer’s dementia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.